Orchestra BioMed Holdings, Inc. rose 17.9% on Friday, November 13, 2026, on 1,564,544 shares, 4.0 times its average daily volume. No headline about OBIO came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.
Orchestra BioMed Holdings, Inc. (OBIO:NASDAQ) closed at $7.25 on November 13, 2026, up 17.89% on the day. The stock trades 1.6% below its 52-week high of $7.37 and 109.5% above its 52-week low of $3.46. Over the past year, it gained 75.5%. Orchestra BioMed Holdings, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, OBIO closed higher on 118 days (47%). Its best day was August 18, 2026 (+19.92%) and its worst was May 15, 2026 (-9.49%). The stock moved 10% or more in a single session 7 times. It opened at least 5% above the previous day's high 1 time.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. Orchestra BioMed's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
Find more stocks like OBIO with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.